Process Engineering Co-op, LNP Development
Beam Therapeutics
Summary
Beam is looking for a highly energetic Process Engineering Co-op to join our growing LNP Development Team from January through June 2027. In this role, you will contribute to scale-up activities for Lipid Nanoparticle formulations and process development, troubleshooting strategies and data driven experimental designs for next-generation LNP formulations. You will work closely with the development team along with collaborating cross-functionally within a fast-paced environment to develop robust and scalable LNPs.
Job description
Position Overview
Beam is looking for a highly energetic Process Engineering Co-op to join our growing LNP Development Team from January through June 2027. In this role, you will contribute to scale-up activities for Lipid Nanoparticle formulations and process development, troubleshooting strategies and data driven experimental designs for next-generation LNP formulations. You will work closely with the development team along with collaborating cross-functionally within a fast-paced environment to develop robust and scalable LNPs.
Responsibilities
- Support the development, optimization, and scale-up of targeted lipid nanoparticle (tLNP) manufacturing processes.
- Conduct formulation and process development studies involving LNP mixing, filtration, and tangential flow filtration (TFF) to evaluate and understand key product quality attributes.
- Execute laboratory experiments to assess process performance and characterize the impact of critical process parameters on LNP quality, stability, and manufacturability.
- Contribute to process improvement initiatives through experimental design, data analysis, and troubleshooting of formulation and manufacturing challenges.
- Collaborate with cross-functional teams across LNP Development, Analytical Development, and Process Optimization to advance project objectives.
- Maintain accurate documentation of experimental activities, analyze results, and present to the project team.
- Follow all laboratory safety policies and procedures while supporting routine laboratory operations.
Qualifications
- Pursuing a BS or MS in Bioengineering, Biochemistry or any related field of study with at least 1 year of relevant experience.
- Strong interest in drug delivery, bioprocess development, or pharmaceutical manufacturing.
- Knowledge of Excel, PowerPoint, and data analytics tools required.
- Comfortable working in a highly collaborative, fast-paced environment with cross-functional teams.
- Strong analytical and critical thinking skills, with familiarity with process engineering concepts.
- Highly motivated to learn, with excellent organizational, communication, and time management skills.
- Applicants must be currently enrolled in a degree-granting college or university program and maintain their student status throughout the duration of the co-op to be eligible.
Requirements
- Pursuing a BS or MS in Bioengineering, Biochemistry or any related field of study with at least 1 year of relevant experience
- Strong interest in drug delivery, bioprocess development, or pharmaceutical manufacturing
- Knowledge of Excel, PowerPoint, and data analytics tools required
- Comfortable working in a highly collaborative, fast-paced environment with cross-functional teams
- Strong analytical and critical thinking skills, with familiarity with process engineering concepts
- Highly motivated to learn, with excellent organizational, communication, and time management skills
- Applicants must be currently enrolled in a degree-granting college or university program and maintain their student status throughout the duration of the co-op to be eligible
Company overview
Beam Therapeutics is a pioneering biotechnology company focused on developing precision genetic medicines through base editing technology. Founded by leading CRISPR researchers, the company leverages its proprietary base editing platform to create therapies that can make precise, single-letter changes to DNA without causing double-strand breaks. Beam's innovative approach addresses genetic diseases at their source by correcting point mutations that cause various inherited disorders. The company's pipeline includes programs targeting sickle cell disease, beta-thalassemia, and other genetic conditions. Beam Therapeutics represents the next generation of gene editing companies, building upon CRISPR technology to enable more precise and potentially safer genetic modifications. The company has established strategic partnerships and collaborations to advance its therapeutic programs and expand the applications of its base editing technology across multiple disease areas.